Position in BIOA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$592,893
+$58,560 QoQ
Shares Held
33,899
-16.1% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $63,936,746 across 33 Drug Manufacturers - Specialty & Generic names. BIOA ranks #14 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
149,111 | $19,643,883 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
29,124 | $17,269,949 | |
| 3 | ZTS |
Zoetis Inc.
|
59,483 | $7,031,485 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
92,067 | $5,092,225 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
82,169 | $2,504,511 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
509,247 | $1,787,456 | |
| 7 | VTRS |
Viatris Inc
|
126,728 | $1,712,095 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
21,817 | $1,677,727 |
All Filings in BIOA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $592,893 | 33,899 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $534,333 | 40,388 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $711,062 | 120,929 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||